Search Results - Mustafa Sahbazlar
- Showing 1 - 8 results of 8
-
1
-
2
-
3
-
4
-
5
SUVmax-IPI as a New Prognostic Index in Metastatic Non-Small Cell Lung Cancer Patients Receiving Nivolumab by Nagihan Kolkıran, Atike Pınar Erdoğan, Mustafa Şahbazlar, Semra Taş, Gamze Gököz Doğu, Kübra Canaslan, İlkay Tuğba Ünek, Özge Demirkıran, Bilgin Demir, Güler Nur Teküstün, Özgür Tanrıverdi, Ferhat Ekinci
Published in Current Oncology (2025-10-01)Get full text
Article -
6
Prognostic impact of hand-foot skin reaction in regorafenib-treated adult-type diffuse gliomas: A multicenter Turkish Oncology Group study by Safa Can Efil, Burak Bilgin, Irem Bilgetekin, Kaan Helvaci, Teoman Sakalar, Erdinc Nayir, Fatma Esra Erdem Palaz, Ali Kaan Guren, Sedat Biter, Taha Koray Sahin, Ertugrul Bayram, Neyran Kertmen, Ahmet Melih Arslan, Esra Asık, Orhun Akdogan, Ozkan Alan, Evren Fidan, Ozan Yazici, Elif Sahin, Engin Kut, Ceren Mordag Cicek, Sema Turker, Nagihan Kolkiran, Gamze Gokoz Dogu, Mustafa Sahbazlar, Aziz Batu, Bilgesah Kilictas, Mesut Yilmaz, Nejat Emre Oksuz, Mehmet Artac, Sinem Akbas, Efnan Algin, Yuksel Urun, Mehmet Ali Nahit Sendur, Bulent Yalcin
Published in Scientific Reports (2025-10-01)Get full text
Article -
7
Author Correction: The prognostic impact of Her2 status in early triple negative breast cancer: a Turkish Oncology Group (TOG) study by Neslihan Özyurt, Ali Alkan, Burcu Gülbağcı, Mustafa Seyyar, Esra Aşık, Mustafa Şahbazlar, Mehmet Türker, Oğuzcan Kınıkoğlu, Tahir Yerlikaya, Gülhan Dinç, Ali Aytaç, Ziya Kalkan, Senar Ebinç, İlkay Gültürk, Merve Keskinkılıç, Zehra Sucuoğlu İşleyen, Dilek Çağlayan, Alper Türkel, Esra Aydın, Teoman Şakalar, Serhat Sekmek, Nilgün Yıldırım, Sinem Koçak, Kerem Okutur, Ahmet Özveren, Bengü Dursun, Sait Kitaplı, Orhan Önder Eren, İsmail Beypınar, İlhan Hacıbekiroğlu, Devrim Çabuk, Elanur Karaman, Ömer Acar, Semra Paydaş, Melek Karakurt Eryılmaz, Bilgin Demir, Zeynep Oruç, Mesut Yılmaz, Fatih Selçuk Biricik, Derya Kıvrak Salim, Özgür Tanrıverdi, Mutlu Doğan
Published in Scientific Reports (2025-03-01)Get full text
Article -
8
The prognostic impact of Her2 status in early triple negative breast cancer: a Turkish Oncology Group (TOG) study by Neslihan Özyurt, Ali Alkan, Burcu Gülbağcı, Mustafa Seyyar, Esra Aşık, Mustafa Şahbazlar, Mehmet Türker, Oğuzcan Kınıkoğlu, Tahir Yerlikaya, Gülhan Dinç, Ali Aytaç, Ziya Kalkan, Senar Ebinç, İlkay Gültürk, Merve Keskinkılıç, Zehra Sucuoğlu İşleyen, Dilek Çağlayan, Alper Türkel, Esra Aydın, Teoman Şakalar, Serhat Sekmek, Nilgün Yıldırım, Sinem Koçak, Kerem Okutur, Ahmet Özveren, Bengü Dursun, Sait Kitaplı, Orhan Önder Eren, İsmail Beypınar, İlhan Hacıbekiroğlu, Devrim Çabuk, Elanur Karaman, Ömer Acar, Semra Paydaş, Melek Karakurt Eryılmaz, Bilgin Demir, Zeynep Oruç, Mesut Yılmaz, Fatih Selçuk Biricik, Derya Kıvrak Salim, Özgür Tanrıverdi, Mutlu Doğan
Published in Scientific Reports (2024-10-01)Get full text
Article
